Ilya Rachman

Chief Executive Officer at IMMIX BIOPHARMA, INC.

Net worth: 2 M $ as of 2024-04-29

52 year

Consumer Services

Health Technology

Profile

Ilya Rachman is the founder of Immix Biopharma, Inc., where he holds the title of Chairman & Chief Executive Officer since 2012.
He is also the founder of Nexcella, Inc., where he currently serves as the Executive Chairman.
Dr. Rachman has an MBA from the University of California, Los Angeles, and has completed graduate and doctorate degrees from the University of Illinois.
He also holds an undergraduate degree from the University of Iowa.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
IMMIX BIOPHARMA, INC. 4.28%	2024-05-19	1,130,359 ( 4.28% )	2 M $	2024-04-29

Ilya Rachman active positions

Companies	Position	Start
IMMIX BIOPHARMA, INC.	Chief Executive Officer	2011-12-31
Nexcella, Inc. Nexcella, Inc. BiotechnologyHealth Technology Part of Immix Biopharma, Inc., Nexcella, Inc. is a clinical-stage biopharmaceutical company based in Los Angeles, CA. The company is engaged in the discovery and development of novel cell therapies for oncology and other indications. Nexcella's lead candidate, next generation bcma-targeted car-t nxc-201, has produced high response rates in relapsed/refractory al amyloidosis and relapsed/refractory multiple myeloma, and has been awarded orphan drug designation by the FDA in both indications. The company's n-genius platform allows for the discovery, development, and manufacture of cutting-edge cell therapies for patients in need. Expansion into autoimmune indications is planned.	Chairman	-

All active positions of Ilya Rachman

Training of Ilya Rachman

University of Illinois	Doctorate Degree
University of Iowa	Undergraduate Degree
University of California, Los Angeles	Masters Business Admin

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Ilya Rachman's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
IMMIX BIOPHARMA, INC.	Health Technology

Private companies	1
Nexcella, Inc. Nexcella, Inc. BiotechnologyHealth Technology Part of Immix Biopharma, Inc., Nexcella, Inc. is a clinical-stage biopharmaceutical company based in Los Angeles, CA. The company is engaged in the discovery and development of novel cell therapies for oncology and other indications. Nexcella's lead candidate, next generation bcma-targeted car-t nxc-201, has produced high response rates in relapsed/refractory al amyloidosis and relapsed/refractory multiple myeloma, and has been awarded orphan drug designation by the FDA in both indications. The company's n-genius platform allows for the discovery, development, and manufacture of cutting-edge cell therapies for patients in need. Expansion into autoimmune indications is planned.	Health Technology